Abbreviations Akt: Protein kinase B BMI: Body mass index cAMP: Cyclic adenosine monophosphate CGRP: Calcitonin gene-related peptide DM: Diabetes mellitus DPP: 4-dipeptidyl peptidase-4 GLP: 1-glucagon-like peptide-1 GLP: 1R-glucagon-like peptide-1 receptor HbA1c: Glycated hemoglobin IGF: Insulin-like growth factor MAPK: Mitogen-activated protein kinase mTOR: Mammalian target of rapamycin NF: B-nuclear factor B PI3K: Phosphoinositide 3-kinase PKA: cAMP-dependent protein kinase SGLT: 2-sodium-glucosecotransporter-2 T2DM: Type 2 diabetes mellitus References Iijima, T., Shibuya, M., Ito, Y., & Terauchi, Y
10.1021/bi00064a021 19 GutscherM.PauleauA.-L.MartyL.BrachT.WabnitzG
The primary endpoint was the presence of increased RCG, defined as, the presence of solids, thick liquids, or more than 1.5 mL/kg of clear liquids on gastric ultrasonography. Among the 124 subjects (median age, 56 years, 60% female), the prevalence of increased RGC was 56% (35 of 62) in subjects with GLP-1 RA use compared with 19% (12 of 62) in subjects not taking a GLP-1 RA drug
The tannin is typical in people with darker skin and can be permanent, although rare
Serious adverse event rates were comparable with placebo, although gastrointestinal events were slightly more frequent in the semaglutide group versus placebo (5.0% vs 4.4%)